Cargando…
Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
The epidemic of obesity, type 2 diabetes and nonalcoholic liver disease (NAFLD) favors drug consumption, which augments the risk of adverse events including liver injury. For more than 30 years, a series of experimental and clinical investigations reported or suggested that the common pain reliever...
Autores principales: | Begriche, Karima, Penhoat, Clémence, Bernabeu-Gentey, Pénélope, Massart, Julie, Fromenty, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879315/ https://www.ncbi.nlm.nih.gov/pubmed/36713231 http://dx.doi.org/10.3390/livers3010003 |
Ejemplares similares
-
Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity
por: Massart, Julie, et al.
Publicado: (2017) -
Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease
por: Massart, Julie, et al.
Publicado: (2022) -
Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver
por: Massart, Julie, et al.
Publicado: (2022) -
Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity
por: Allard, Julien, et al.
Publicado: (2020) -
Impact of malnourishment on the pharmacokinetics of acetaminophen and susceptibility to acetaminophen hepatotoxicity
por: Zillen, Daan, et al.
Publicado: (2021)